Remove 2028 Remove Biosimilars Remove Research
article thumbnail

Drug discovery informatics market predicted to grow 12.6% by 2028

Drug Discovery World

billion in 2028 at a compound annual growth rate (CAGR) of 12.6%, according to analysts ResearchAndMarkets.com. An increase in research and development (R&D) activity will also have an impact. by 2028 appeared first on Drug Discovery World (DDW). The drug discovery informatics market is predicted to grow from $3.77

Marketing 130
article thumbnail

The Competitive Edge of Biosimilars

DrugBank

Biosimilars  Biosimilars, while highly similar to their reference biopharmaceuticals, offer distinct advantages that position them as preferred therapeutic options in many cases. This is because biosimilars are not new drugs but highly similar versions of already approved therapies with established safety and efficacy profiles.

article thumbnail

Investment Trends in Pharmaceutical Research

DrugBank

Investment Trends in Pharmaceutical Research and Development Investing in the pharmaceutical sector presents a unique set of challenges and opportunities; let’s examine them in more detail.  trillion by 2028. billion by 2028, demonstrating the urgent need for effective treatments.